Patent ID: 7722903
Filing Date: 2010-05-25
Classification: A61K,A61P

Abstract:
1. A method of treating a pathological condition associated with prostaglandins (PGs) production in a mammal, the method comprising inhibition of inducibility or activity of cyclooxygenase 2 (COX2) by administering to the mammal an effective amount of a composition comprising about 50 to 7500 mg of a compound selected from the group consisting of dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, tetrahydro-isoadhumulone, hexahydro-isohumulone, hexahydro-isocohumulone, and hexahydro-isoadhumulone, wherein the pathological condition is selected from the group consisting of arthritis, asthma, tendonitis, bursitis, gastrointestinal conditions, pulmonary inflammation, allergic rhinitis, and atherosclerosis.